Mosapride: Scientific Interpretation and Application Guide for Gastrointestinal Motility Drugs

Mosapride is a selective 5-HT4 receptor agonist, mainly used to treat gastrointestinal motility disorders such as functional dyspepsia and gastroesophageal reflux disease. This article will expand on the pharmacological effects, clinical applications, precautions and manufacturers to help readers fully understand this drug. The content is divided into five parts: first, it outlines the core points, then analyzes its mechanism of action, indications and efficacy, medication precautions, and finally summarizes the key information and attaches authoritative data.

Paragraph 2: Mosapride’s pharmacological mechanism and core functions

Mosapride stimulates the 5-HT4 receptors in the intestinal plexus and promotes the release of acetylcholine, thereby enhancing gastrointestinal motility and gastric emptying. Unlike traditional dopamine receptor antagonists such as domperidone, mosaprideDoes not penetrate the blood-brain barrier, avoiding central nervous system side effects. Studies have shown that it can significantly improve symptoms such as fullness and nausea after meals, and is especially suitable for patients with gastroparesis. China's "Expert Consensus on Functional Dyspepsia" lists it as a first-line recommended drug (citation source: "Chinese Journal of Digestion" 2021 edition).

Paragraph 3: Verification of indications and clinical efficacy

Mosapride is mainly used for functional dyspepsia (FD) and chronic gastritis with motility disorders. It also has a clear effect on the adjuvant treatment of gastroesophageal reflux disease (GERD). Clinical trials have shown that after patients took it for 4 weeks, the relief rate of upper abdominal pain and early satiety reached more than 70% (data source: J Gastroenterol Hepatol 2019). It should be noted that this medicineNot suitable for organic diseases such as intestinal obstruction or gastrointestinal bleeding, and should be used with caution by pregnant and lactating women. When taking the medicine together, it is necessary to avoid taking it with anticholinergic drugs to avoid reducing the efficacy.

Paragraph 4: Medication Precautions and Adverse Reactions

Common adverse reactions include diarrhea and abdominal pain (incidence rate is about 3%-5%), which are usually mild and can resolve spontaneously. Liver function needs to be monitored with long-term use, and QT interval prolongation has been reported in rare cases. It is recommended to take the medicine 15-30 minutes before meals, 3 times a day. Elderly patients do not need to adjust the dose, but those with heart disease should be cautious. Japanese scholar Oto Masaki pointed out in "Gastrointestinal Pharmacology" that the effects of mosaprideSafer than erythromycin-based kinetic drugs, but it is necessary to avoid combination with strong CYP3A4 inhibitors.

Paragraph 5: Summary and production information

Mosapride, as a highly effective gastrointestinal motility drug, is both safe and targeted, but the indications must be strictly followed. Major domestic manufacturers include Qilu Pharmaceutical (trade name: Ruiqi), Jiangsu Hansoh (trade name: Xinluona), etc. The dosage forms are mostly tablets or dispersible tablets. Patients should consult a doctor before taking medication and comprehensively manage symptoms by adjusting their diet (such as eating smaller meals more often). The following table lists common product information:

Cited sources: 1. "Chinese Expert Consensus on Functional Dyspepsia" (2021); 2. Masaki Oto, "Gastrointestinal Pharmacology" (2018); 3. State Drug Administration Drug Database.